Medicare patients who accessed opioid use disorder treatment through telehealth services during the pandemic were more likely to stay in treatment and less likely to experience an overdose than patients without telehealth access to OUD treatment, according to a federal study published last week in JAMA Psychiatry.

“Telehealth is a valuable service and when coupled with medications for opioid use disorder can be lifesaving,” said Wilson Compton, M.D., deputy director of the National Institute on Drug Abuse and senior author of the study. “This study adds to the evidence showing that expanded access to these services could have a longer-term positive impact if continued.”

Related News Articles

Headline
The Medicare Payment Advisory Commission Dec. 4 and 5 discussed draft payment update recommendations for 2027, which the commission will vote on in January.…
Headline
President Trump Dec. 1 signed the AHA-supported SUPPORT Act (H.R. 2483) into law. The legislation reauthorizes key prevention, treatment and recovery programs…
Headline
The House Dec. 1 passed the Hospital Inpatient Services Modernization Act (H.R. 4313), legislation extending certain Medicare waivers authorizing the hospital-…
Headline
The AHA provided recommendations to the Food and Drug Administration Dec. 1 in response to a request for information on the measurement and evaluation of…
Headline
The Centers for Medicare & Medicaid Services announced Dec. 1 that it intends to expand the Inpatient Rehabilitation Facility Review Choice Demonstration…
Headline
The Food and Drug Administration has identified a Class I recall of Baxter Life2000 Ventilation Systems due to a cybersecurity issue discovered through…